Mycophenolate mofetil in dysimmune neuropathies: A preliminary study
- 24 March 2004
- journal article
- letter
- Published by Wiley in Muscle & Nerve
- Vol. 29 (5), 748-749
- https://doi.org/10.1002/mus.20024
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Mycophenolate in treatment‐resistant inflammatory neuropathiesEuropean Journal of Neurology, 2002
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositisJournal of the Neurological Sciences, 2001
- Clinical spectrum of chronic acquired demyelinating polyneuropathiesMuscle & Nerve, 2001
- Mycophenolate mofetil for myasthenia gravis: An open-label pilot studyNeurology, 2001
- Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseasesNeurology, 2001
- Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatmentAnnals of Neurology, 2000
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991